Literature DB >> 15214139

Using a new lipidocolloid dressing in paediatric wounds: results of French and German clinical studies.

A Letouze1, V Voinchet, B Hoecht, K C Muenter, R Vives, S Bohbot.   

Abstract

OBJECTIVE: To evaluate the efficacy, tolerance and acceptability of a lipidocolloid dressing, Urgotul (Laboratoires Urgo), in the local treatment of acute and chronic paediatric wounds.
METHOD: Two non-comparative multicentre prospective clinical studies were conducted using the same protocol in France and Germany. A total of 100 patients were recruited from 16 centres (11 in France and five in Germany), and followed up for four weeks. Seventy wounds (55 burns and 15 other wounds) from France and 30 from Germany (22 burns and eight other wounds) were evaluated by nursing staff at every dressing change and by the medical investigator on a weekly basis.
RESULTS: In the French study population, 86% of the burns (superficial and deep partial-thickness) and 53% of the other wounds healed completely within the four weeks. Figures for the German study population were 100% and 88% respectively. Pain was evaluated using pain scales adapted to the patient's age (objective pain scale, faces scale for pain and a visual analogue scale) at each dressing change. Dressing removal was non-traumatic, inducing very limited pain. Minor local adverse events were reported in four children.
CONCLUSION: Urgotul is not only efficacious, but also well-tolerated and accepted by children with acute and chronic wounds. The dressing, therefore, might be an appropriate and highly promising alternative to conventional dressings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15214139     DOI: 10.12968/jowc.2004.13.6.26630

Source DB:  PubMed          Journal:  J Wound Care        ISSN: 0969-0700            Impact factor:   2.072


  3 in total

1.  A randomised, controlled, non-inferiority trial comparing the performance of a soft silicone-coated wound contact layer (Mepitel One) with a lipidocolloid wound contact layer (UrgoTul) in the treatment of acute wounds.

Authors:  Franck David; Jean-Louis Wurtz; Nicolas Breton; Olivier Bisch; Philippe Gazeu; Jean-Charles Kerihuel; Odile Guibon
Journal:  Int Wound J       Date:  2017-12-05       Impact factor: 3.315

2.  The use of Urgotul in the treatment of partial thickness burns and split-thickness skin graft donor sites: a prospective control study.

Authors:  Pearlie W W Tan; Wong Chin Ho; Colin Song
Journal:  Int Wound J       Date:  2009-08       Impact factor: 3.315

3.  Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial.

Authors:  Jean-Luc Schmutz; Sylvie Meaume; Ségolène Fays; Zohva Ourabah; Bernard Guillot; Valéne Thirion; Mark Collier; Simon Barrett; J Smith; Serge Bohbot; Anne Dompmartin
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.